Clinical Trial Update: FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating fecal microbiota transplantation to decolonize patients carrying carbapenem-resistant Enterobacteriaceae; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Enterobacteriaceae Infections, Multi-antibiotic Resistance | Phase 1, Phase 2 | Status: RECRUITING